The estimated Net Worth of James Michael Phillips is at least $502 Tausend dollars as of 24 March 2020. James Phillips owns over 2,760 units of Pacific Biosciences of California Inc stock worth over $418,690 and over the last 13 years James sold PACB stock worth over $82,888.
James has made over 9 trades of the Pacific Biosciences of California Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently James sold 2,760 units of PACB stock worth $8,418 on 24 March 2020.
The largest trade James's ever made was exercising 31,663 units of Pacific Biosciences of California Inc stock on 7 August 2015 worth over $22,164. On average, James trades about 7,381 units every 97 days since 2011. As of 24 March 2020 James still owns at least 249,220 units of Pacific Biosciences of California Inc stock.
You can see the complete history of James Phillips stock trades at the bottom of the page.
James's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025.
Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan und Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.
pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.
Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include: